Literature DB >> 8995481

Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization.

M Bentz1, U S Bergerheim, C Li, S Joos, C A Werner, M Baudis, J Gnarra, M J Merino, B Zbar, W M Linehan, P Lichter.   

Abstract

We used comparative genomic hybridization to analyze 17 tumor samples from 11 patients with papillary renal cell carcinoma (RCC), including three patients with hereditary papillary RCC. Whereas the most frequent aberrations confirmed data obtained by banding analyses, copy number increases on 5q, which previously were considered characteristic of nonpapillary RCC, were identified in two cases. In two complex cases belonging to the same family, a characteristic pattern of chromosomal aberrations was found: five of the six imbalances present in the less complex case were included in the karyotype of the other case, suggesting a genetically determined mechanism resulting in genomic instability of specific chromosomes or chromosomal subregions and/or selection of specific mutations.

Entities:  

Mesh:

Year:  1996        PMID: 8995481     DOI: 10.1159/000134448

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  10 in total

1.  Clonal trisomies 7,10 and 12, normal 3p and absence of VHL gene mutation in a clear cell tubulopapillary carcinoma of the kidney.

Authors:  Alexander Wolfe; Sheila M Dobin; Petr Grossmann; Michal Michal; Ludvik R Donner
Journal:  Virchows Arch       Date:  2011-08-07       Impact factor: 4.064

2.  Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype.

Authors:  I A Lubensky; L Schmidt; Z Zhuang; G Weirich; S Pack; N Zambrano; M M Walther; P Choyke; W M Linehan; B Zbar
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

3.  Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutation.

Authors:  Hongjuan Zhao; Rosalie Nolley; Andy M W Chan; Erinn B Rankin; Donna M Peehl
Journal:  Cancer Biol Ther       Date:  2016-08-11       Impact factor: 4.742

Review 4.  Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.

Authors:  Theodore F Logan
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

5.  Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma.

Authors:  Melinda E Sanders; Rosemarie Mick; John E Tomaszewski; Frederic G Barr
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

6.  Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes.

Authors:  F Jiang; J Richter; P Schraml; L Bubendorf; T Gasser; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 7.  Comparative genomic hybridization and chromosomal instability in solid tumours.

Authors:  P H Rooney; G I Murray; D A Stevenson; N E Haites; J Cassidy; H L McLeod
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

8.  Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution.

Authors:  Michal Kovac; Carolina Navas; Stuart Horswell; Max Salm; Chiara Bardella; Andrew Rowan; Mark Stares; Francesc Castro-Giner; Rosalie Fisher; Elza C de Bruin; Monika Kovacova; Maggie Gorman; Seiko Makino; Jennet Williams; Emma Jaeger; Angela Jones; Kimberley Howarth; James Larkin; Lisa Pickering; Martin Gore; David L Nicol; Steven Hazell; Gordon Stamp; Tim O'Brien; Ben Challacombe; Nik Matthews; Benjamin Phillimore; Sharmin Begum; Adam Rabinowitz; Ignacio Varela; Ashish Chandra; Catherine Horsfield; Alexander Polson; Maxine Tran; Rupesh Bhatt; Luigi Terracciano; Serenella Eppenberger-Castori; Andrew Protheroe; Eamonn Maher; Mona El Bahrawy; Stewart Fleming; Peter Ratcliffe; Karl Heinimann; Charles Swanton; Ian Tomlinson
Journal:  Nat Commun       Date:  2015-03-19       Impact factor: 14.919

9.  Molecular cytogenetic analysis of 17 renal cancer cell lines: increased copy number at 5q31-33 in cell lines from nonpapillary carcinomas.

Authors:  Z Q Yang; M A Yoshida; Y Fukuda; N Kurihara; Y Nakamura; J Inazawa
Journal:  Jpn J Cancer Res       Date:  2000-02

10.  Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data.

Authors:  Michael Baudis
Journal:  BMC Cancer       Date:  2007-12-18       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.